Skip to main content
. 2011 Sep;55(9):4443–4446. doi: 10.1128/AAC.01513-10

Table 1.

MICs of β-lactams for E. coli MEV, the E. coli TOP10(pMEV) and TOP10(pAmpC-A) recombinant clones, and the E. coli TOP10 recipient strain

β-Lactam E. coli MEVa E. coli MEVa + CLOXAc E. coli MEVa + PAβNd E. coli TOP10(pMEV)a E. coli TOP10(pAmpC-A)a E. coli TOP10
Amoxicillin >512 16 >512 >512 512 2
Amoxicillin-CLAb 512 8 512 512 512 2
Ticarcillin 256 4 128 256 8 1
Ticarcillin-CLAb 128 4 64 128 8 1
Piperacillin 256 4 128 256 8 1
Piperacillin-TZBe 128 4 64 64 8 1
Cefotaxime 64 0.5 16 32 1 0.06
Ceftazidime 256 1 128 256 2 0.06
Cefepime 16 0.5 2 2 0.06 0.06
Imipenem 0.5 0.25 0.5 0.25 0.06 0.06
Ertapenem 1 0.06 0.5 0.125 0.016 0.008
Meropenem 0.25 0.125 0.25 0.032 0.032 0.032
a

E. coli MEV and TOP10(pMEV) produced the extended-spectrum AmpC-MEV β-lactamase, E. coli TOP10(pAmpC-A) produced the narrow-spectrum AmpC-A β-lactamase, and the E. coli TOP10 recipient strain did not produce a β-lactamase.

b

CLA, clavulanic acid at 2 μg/ml.

c

Cloxacillin (CLOXA) MICs were obtained using 250 μg/ml cloxacillin-containing Mueller-Hinton agar plates.

d

PAβN was used at 26.3 μg/ml (5).

e

TZB, tazobactam at 4 μg/ml.